These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 5585427)

  • 1. [Therapeutic results with the cerebral vasodilator agent Instenon].
    Salomon K
    Wien Klin Wochenschr; 1967 Jun; 79(26):546-8. PubMed ID: 5585427
    [No Abstract]   [Full Text] [Related]  

  • 2. [Action of pyrithioxine combined with a vasodilator in patients with cerebral arteriosclerosis].
    Schlesinger P
    Rev Bras Med; 1972 Jan; 29(1):38-41. PubMed ID: 4552863
    [No Abstract]   [Full Text] [Related]  

  • 3. [Indications for Ustimon and Instenon therapy in cerebrovascular diseases].
    Eichhorn O
    Wien Klin Wochenschr; 1967 Jan; 79(4):67-71. PubMed ID: 5340281
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies of the administration of ustimon and instenon in cerebrovascular diseases].
    Pichler E; Strauss A
    Wien Klin Wochenschr; 1968 Jan; 80(4):61-4 passim. PubMed ID: 5667714
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of peripheral and cerebral circulation disorders. Experiences with bencyclan-hydrogenfumarate (Fludilat)].
    Frercks J
    Munch Med Wochenschr; 1971 Oct; 113(40):1293-8. PubMed ID: 5171108
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experiences with a new xanthine derivative in central and peripheral blood circulation disorders].
    Hirsch W; Woschée GJ
    Ther Ggw; 1971 Nov; 110(11):1668 passim. PubMed ID: 5158649
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical study of a new vasodilating agent (Dilydrin) in cerebral vascular disorders and strokes].
    Probst G; Keiser G
    Praxis; 1969 Dec; 58(50):1653-8. PubMed ID: 4905566
    [No Abstract]   [Full Text] [Related]  

  • 8. [Vasoactive combination treatment in cerebrovascular sclerosis].
    Klein K
    Wien Med Wochenschr; 1973 Jan; 123(1):14-8. PubMed ID: 4405190
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical experimentation with a combination of substances having vasodilator effects on the cerebral circulation].
    Barbi G; Tallone G
    Minerva Med; 1967 Feb; 58(13):489-91. PubMed ID: 6021620
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the treatment of cerebral nutrition disorders. A double blind study].
    Kirchberger F; Kehl R; Gutmann W
    Med Welt; 1969 Jul; 27():1542-6. PubMed ID: 4895204
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of mental manifestations of chronic cerebral circulatory insufficiency. Clinical and psychometric study].
    Lefebvre P; Crocq L; Bernard JG
    Sem Hop; 1969 Jan; 45(5):312-7. PubMed ID: 4307724
    [No Abstract]   [Full Text] [Related]  

  • 12. Results obtained with Sturgeron applied in progressive cerebral arteriosclerosis patients controlled systematically for years.
    Hunyi L
    Ther Hung; 1974; 22(1):32-4. PubMed ID: 4844929
    [No Abstract]   [Full Text] [Related]  

  • 13. [A comparative evaluation of the effect of vasodilator drugs on the cerebral vessels of patients with cerebral atherosclerosis (rheoencephalographic studies)].
    Eninie GI; Smeltere ES
    Klin Med (Mosk); 1972 Sep; 50(9):39-44. PubMed ID: 4652968
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical experiences with hexobendine in coronary disease].
    Eral N
    Arzneimittelforschung; 1968 Aug; 18(8):1094-103. PubMed ID: 5755844
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic use of a nicofuranosio-centrophenoxine association in involutive psychoses].
    Viviano M; Ceccarelli G
    Minerva Med; 1966 Nov; 57(94):3965-9. PubMed ID: 4380869
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cyclospasmol 400 in cerebral circulation insufficiency].
    Warot P
    Lille Med; 1973; 18(7):842-4. PubMed ID: 4603446
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experiences with Trental in peripheral circulatory disorders and cerebrovascular insufficiency (author's transl)].
    Schafé MK
    Munch Med Wochenschr; 1973 Oct; 115(40):1745-9. PubMed ID: 4801042
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the use of cinnarizine dihydrochloride in the treatment of arteriosclerotic cerebropathy].
    Di Lorenzo S; Costagliola A; Lampasi D; Alfano S
    Minerva Cardioangiol; 1974 Dec; 22(12):867-70. PubMed ID: 4459730
    [No Abstract]   [Full Text] [Related]  

  • 19. [Value of vasodilator agents in neuropsychiatric practice and study of the indications for Praxilene].
    Bornstein S; Sère de Rivières H
    Therapeutique; 1972 Jan; 48(1):27-34. PubMed ID: 5046366
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of cyclandelate on psychological test performance in patients with cerebral vascular insufficiency.
    Smith WL; Lowrey JB; Davis JA
    Curr Ther Res Clin Exp; 1968 Dec; 10(12):613-8. PubMed ID: 4972756
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.